We investigated the effects of nifedipine on left ventricular diastolic function in 17 (Circulation 1990;81:593-601) It is well known that hypertrophic cardiomyopathy is usually associated with abnormal left ventricular isovolumic relaxationl-5 and diastolic filling.1,2,5,6 Several recent studies have indicated that calcium blocking agents, especially verapamil, produce beneficial effects on diastolic dysfunction in some patients with hypertrophic
The left ventricular pressure-volume curves were constructed before and after nifedipine administration ( Figure 1 ). To assess the alterations in left ventricular diastolic chamber compliance, we plotted diastolic pressure-volume relations in all 14 patients from the point of minimal left ventricular pressure to the top of the atrial pressure waveform.
To define the baseline left ventricular function in this study population, we compared the data of these patients with those of 27 normal subjects who underwent diagnostic cardiac catheterization but who were found to have normal cardiac anatomy and function.
Statistical Analysis
The variables obtained at control and after nifedipine administration were analyzed with the paired t test. An intergroup comparison was performed with an unpaired t test. A significant difference was indicated by ap value less than 0.05 in paired and unpaired t tests. Values are expressed as the mean±SD.
Results

Baseline Left Ventricular Systolic and Diastolic Functions
All patients had normal left ventricular systolic pump function. The cardiac index, ejection fraction, and peak positive dP/dt were not significantly different from the normal values of 3.5±+0.6 1/min/m2, 0.68+0.05 and 1,364+208 mm Hg/sec, respectively (Table 1) . Left ventricular relaxation, diastolic filling, and compliance, however, were abnormal with prolonged isovolumic pressure decay, increased TPFR, and an upward shift of the diastolic pressure-volume relation. The time constant of pressure decay (tiie) was significantly prolonged compared with that of normal subjects (38±5 msec, p<O.01). The TPFR was significantly greater than that of normal subjects (162±25 msec, p<0.01). This prolongation of the TPFR, in part, was a result of prolonged isovolumic relaxation time (normal subjects, 92±13 msec, p<0.01). Time from mitral valve opening to the PFR could be adequately measured in nine of the 14 patients. For this subgroup, there was no significant difference in this value compared with that from the normal control group (the nine patients, 82+30 msec; normal subjects, 70+21 msec; NS). For the five other patients, a distinct moment of the PFR could not be identified within the interval from mitral valve opening to the onset of atrial contraction. This suggests continuous slow filling throughout diastole in these five patients. The PFR and normalized PFR identified from mitral valve opening to the onset of atrial contraction in nine patients were not significantly different from those in normal subjects (502± 160 ml/sec and 5.5 ± 1.2 sec-1). The value of left ventricular end-diastolic pressure of the patients was greater than that of the normal subjects (9±3 mm Hg, p<0.05). The left ventricular diastolic pressure-volume relations of the patients, as a whole, shifted upward compared with those of normal subjects. These findings demonstrate that our patients had abnormal left ventricular diastolic function as suggested by impaired relaxation, delayed early diastolic filling, and decreased diastolic compliance, which are all characteristics of hypertrophic cardiomyopathy as previously reported. Nifedipine-induced afterload reduction did not induce left ventricular outflow obstruction in any patient.
Left Ventricular Relaxation and Diastolic Filling
Peak negative dP/dt fell significantly with nifedipine (p<0.01) ( Table 1 ). The isovolumic relaxation time shortened slightly but significantly (p<0.05). There was no significant improvement in left ventricular relaxation as assessed by the time constants of isovolumic pressure decay. (Figure 3) .
The PFR of left ventricular volume during the rapid filling phase was measured in nine patients, in each of whom the diastolic phase of rapid filling, slow filling (diastasis), and atrial contraction could be identified on the time-volume curves. There was a significant increase in the PFR of left ventricular volume after the administration of nifedipine (p<0.05). The mean normalized PFR also increased but not significantly. The TPFR of left ventricular volume was not significantly changed after nifedipine administration. The mitral valve opening pressure increased significantly (p<0.05).
To test the hypothesis that the patients did not respond to nifedipine because of very localized left ventricular hypertrophy in which most of the left ventricular wall was made up of normal myocardium, we examined left ventricular isovolumic relaxation and diastolic filling in 13 patients, excluding those with apical hypertrophy. In the subgroup of 13 patients with asymmetrical septal hypertrophy and concentric hypertrophy, there was no significant improvement in the time constant of left ventricular isovolumic pressure decay, the normalized PFR, and the TPFR (Table 2) .
Left Ventricular Diastolic Compliance
The response of the left ventricular diastolic pressure-volume relation to nifedipine was variable. Lorell et all' and Paulus et al,12 using combined M-mode echocardiography and a catheter-tipped micromanometer, reported that sublingual nifedipine (10 mg) significantly reduced the time constant of left ventricular isovolumic pressure decay, increased peak lengthening rate of left ventricular internal dimension, and improved left ventricular distensibility assessed by the pressure-dimension relation. Paulus et al12 also demonstrated that nifedipine caused more improvement of left ventricular relaxation, diastolic filling, and distensibility in hypertrophic nonobstructive cardiomyopathy compared with nitroprusside. They suggested that the beneficial effects of nifedipine on diastolic mechanics in hypertrophic cardiomyopathy results not only from systemic vasodilation but also from improved cardiac muscle inactivation associated with the relief of subendocardial ischemia or the correction of an intracellular calcium overload or both. 12 Our patients showed a slight but significant increase in left ventricular end-diastolic pressure. Several investigators demonstrated that nifedipine had little or no direct effect on the peripheral venous system in humans.28-30 Kurnik et a129 reported that left ventricular end-diastolic pressure and volume declined after sublingual nifedipine (20 mg) only in patients with impaired left ventricular systolic function. Left ventricular preload reduction, however, was not associated with alteration of peripheral venous hemodynamics, left ventricular chamber stiffness, and the time constant of left ventricular relaxation but was secondary to the improved left ventricular systolic function in response to afterload reduction. 29 The increase of left ventricular enddiastolic pressure in our patients was accompanied by no significant change in right atrial pressure, right ventricular pressure, and left ventricular isovolumic relaxation. Thus, we speculated that an increase of left ventricular pressure might result, in part, from an increase in coronary blood flow (an "erectile" effect) with nifedipine rather than from other factors affecting the left ventricular diastolic pressurevolume relation. The coronary "erectile" effect seemed to be more pronounced in patients with increased ventricular stiffness such as that caused by left ventricular hypertrophy.31 Further studies will be needed to clarify this point.
The common findings of the effects of nifedipine on left ventricular diastolic function in our study and in the studies by Lorell et al"l and Paulus et al12 are a reduction in isovolumic relaxation time and an increase in the PFR of left ventricular volume during the rapid filling period. Isovolumic relaxation time is multifactorially determined by aortic pressure, left atrial pressure (mitral opening pressure), left ventricular end-systolic pressure, the time constant of left ventricular pressure decay, and heart rate. 4 The PFR of left ventricular volume (an index of early diastolic filling) seems to be mainly determined by the isovolumic relaxation rate (the time constant of isovolumic pressure decay), the magnitude of atrioventricular pressure gradient, heart rate,20,21,32-36 and, in part, by ventricular suction.37 In our study, heart rate was maintained at a constant level by right atrial pacing, and the time constant remained unchanged with nifedipine. Therefore, the shortening of the isovolumic relaxation time could be due to an increase in mitral valve opening pressure and a decrease in left ventricular end-systolic pressure. Similarly, an increase in mitral valve opening pressure and ventricular suction associated with reduced left ventricular end-systolic volume might be responsible for increased PFR with nifedipine administration. In fact, when the PFR was normalized for stroke volume, an increase in the normalized PFR was still not significant. Thus, in our study, the significant changes in the isovolumic relaxation time and PFR by nifedipine can be attributed to altered left ventricular loading rather than modification of intrinsic myocardial properties as suggested by the findings of Lorell et al"l and Paulus et al. 12 The fact that we could not find significant improvement in left ventricular relaxation and diastolic compliance clearly contrasts with observations of Lorell et al"l and Paulus et al.12 Several factors could be responsible for the discrepancy between our data and theirs. First, there were differences in the nifedipine dose administered. We administered 20 mg nifedipine sublingually, whereas they administered 10 mg. This is unlikely to be a factor, however, because in a previous study by Betocchi et 
